Public Company

Miromatrix Medical Inc.

About

Miromatrix Medical is a biotechnology company that is a leader in developing bioengineered organs for transplantation. The company has over 118 issued patents worldwide with a technology that can be applied across a range of donor needs. They are focused on developing kidneys (MiroKidney) and livers (MiroLiver) that are transplantable with additional plans for other critical organs like lungs, pancreases and hearts. The company's technology has been tested extensively both in preclinical and animal studies and has been cleared by the FDA in a previously commercialized matrix product.

Overview

Founded 2009
Type Public
Location Eden Prairie, Minnesota, USA

Stock

MIRO $3.26 -0.46% $(0.02)

Latest News

Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session Dec 28, 2022 Benzinga Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for...
Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session Dec 27, 2022 Benzinga Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook...
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session Dec 23, 2022 Benzinga Gainers Expion360 Inc. (NASDAQ: XPON) shares jumped 175% to $2.70 after the company announced it has been selected as the exclusive supplier of high-energy lithium...
Dow Dips Over 800 Points; S&P 500 Down 2.8% Dec 15, 2022 Benzinga U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 800 points. The Dow traded down 2.62% to 33,077.91...
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session Dec 15, 2022 Benzinga Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18...